Market Slip Drags Injective Down 16% Despite Ongoing Developments


Market Slip Drags Injective Down 16% Despite Ongoing Developments

  newsbtc.com 30 August 2024 12:11, UTC

With the market resuming its bearishness today, August 30th, Injective continues to slip and slide. According to CoinGecko, INJ took a nose dive by 16% which slashed any hopes of a short-term recovery.

Although the token’s performance leaves much to be desired, developments on-chain continue to unfold, cementing Injective’s position within the community. Several developments hold the bay against the bears, but the question of when will INJ and the market recover remains.

Injective Announces Release Of Web-Based IDE: Remix Web

In a recent X post, Injective announced the release of the Remix Web IDE, an IDE that is entirely web-based providing developers the flexibility needed to develop powerful on-chain applications. To access the tool, simply visit the website and start building.

1/3 Exciting news!

Announcing the launch of the Remix Web IDE plugin for Injective. This web-based IDE is a gamechanger for the ecosystem, enabling developers to write, test, and deploy smart contracts right from their browser.https://t.co/t7NWnhtelc

— Injective (@injective) August 26, 2024

This revolutionary take on development lowers the bar in building within the Injective ecosystem and provides an example for other networks to follow. According to the blog, the web plugin also has code templates, providing newbies on the platform to create and deploy applications and smart contracts seamlessly.

According to Shayan, the Developer Relations Manager at Injective Labs, one of the biggest struggles of developers is properly installing software dedicated to coding.

As a developer, one of the most frustrating things is having to properly download software before being able to even write a single line of code.

That’s why the new Remix IDE plugin is such a huge breakthrough. No more headaches dealing with making sure you have the latest… https://t.co/Xzb05mX7hb

— Shayan (@0xShayan) August 27, 2024

That’s why the new Remix IDE plugin is such a huge breakthrough. No more headaches dealing with making sure you have the latest versions of Rust or Go installed, whether you’ve selected the ARM or x86 binaries, etc,” said Shayan in his recent X post.

The flexibility afforded by this recent addition to the platform means a new era of development for Injective with both new and experienced developers building on-chain apps and smart contracts on the platform.

Helios-Injective Collabathon To Set New Heights On Web3 Finance

Another development that piqued the interest of both investors and developers is Injective’s partnership with Helios, a Staking-as-a-Service provider, that is already a part of the former’s network as a validator.

According to Helios’s blog post, the “Collabathon” will feature seasoned developers on both sides with a single goal of solving cross-chain identity verification, a challenge which, according to Helios, “will empower projects to confirm singular wallet ownership across multiple chains, enhancing interoperability and user experience.”

The 10-day Collabathon will occur next week, September 2nd.

INJ Revisits $18.02 For Upside Potential

As of this writing, INJ’s trajectory puts it just below $18.02. This revisit of a crucial price ceiling might trigger a rally soon. However, this possibility is hinged on the market’s uncertain movement, which currently screams hawkish.

With this in mind, INJ does have the potential to regain ground in the medium term given that the market flips bullish in the same timeframe. The token’s relative strength index indicates low volatility in the market as both bulls and bears gather momentum for a breakthrough.

In the long term, INJ bulls can target $23.37 to regain lost momentum. However, investors and traders should still exercise caution as the broader market may swing downward depending on the overall sentiment.

Featured image from Pexels, chart from TradingView

Leave a Reply

Your email address will not be published. Required fields are marked *

Back To Top